Clinical Trials

3 results for Bladder Cancer

Phase II Study to Evaluate the Activity of Commercially Available Molecularly Matched Targeted Therapies in Selected Tumor Types Based on Genomic Alterations

  • Condition: Non-small Cell Lung Carcinoma, Urothelial Carcinoma, Gastrointestinal Carcinoma, Non-colon, Upper Aerodigestive Tract Carcinoma
  • Intervention: Drug: afatinib, Drug: regorafenib
  • Study ID: NCT02795156
View Trial

Peking University First Hospital

  • Condition: Upper Tract Urothelial Carcinoma, Bladder Recurrence
  • Intervention: Drug: Pirarubicin
  • Study ID: NCT02740426
View Trial

A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies

  • Condition: Malignant Solid Tumour, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Urothelial Carcinoma, Endometrial Neoplasms, Multiple Myeloma, MPN, Breast Cancer, Cholangiocarcinoma
  • Intervention: Drug: INCB054828, Drug: Gemcitabine+Cisplatin, Drug: Pembrolizumab, Drug: Docetaxel
  • Study ID: NCT02393248
View Trial